Does the Rising Pharma Sector Signaling Better Investing Opportunities for Us?

India enjoys a dominating position in the pharmaceutical market, sharing almost 50 per cent of the global supplies of medicines and sundries. The advanced countries like the US and the UK depend upon India’s chemical excellence for the betterment of their medical advancements, thus making India the largest supplier of generic drugs worldwide. In addition, the country homes one of the largest group of scientists and engineers who dwell the capability to steer the medicinal industry in the near future.

Amidst all this advancement in the pharma sector, mutual fund companies have gathered a new venture for expanding their product line. Many fund houses have initiated sector-based investing primarily pinning on the pharma sector, thus sharing the success of the industry with the investors. Online marketing and investment facility have further accelerated investments in the pharma driven mutual funds, thus making it one of the most likable option in investment.

Rising Online Investing in India

MySIPonline – North India’s leading online investment brand – provides top investment products and an easy online pathway to invest in them. Though just a few years old, the company has taken an enormous lift and has become the favourite spot for mutual fund shopping in India. The fund experts and reviewers heading MySIPonline are known for unbiased opinions on market and its periphery, and have helped thousands of people realise their financial goals. Let’s check their view on the pharma industry in India, and what it holds for the investors in future.

The Reality of India’s Pharma Industry

As discussed above, Indian pharma brands are topping the charts worldwide in exports of various medicinal goods, be it bulk drugs, intermediary supplies, surgical equipment or sundries. In the year 2017, the Indian pharma industry was valued at more than $30 billion, with an expected rise of 22% by the year 2020. Further, the turnover in the domestic market grew by 9.4% like clockwork from a value of $17.87 billion in 2017 to $18.12 billion in 2018. This figure is expected to rise to a whopping $100 billion by 2025, given the fast pace technological advancements and friendly market conditions.

Acceleration in Subscription of Pharma Mutual Funds

With an epic rise in the pharma industry, there has been a substantiate growth in the number of subscribers of pharma mutual funds. Statistics suggest that investors today prefer at least one sector based fund in their portfolio, which mostly pertains to the pharma sector only. As a result of the surge in the pharma industry, the mutual funds in this sector have also showcased outstanding performance in the last five year. Report say that the top performing pharms sector mutual funds have yielded returns as high as 14%, thus becoming one of the most promising investment sectors in India.

The Word of Caution 

Though pharma sector is a high paying industry, the scenario is not always a very profitable one. Like any other industry, pharma sector too is sensitive to government policies which tend to change according to the global market scenarios and current domestic condition. Hence, it is recommended that you should step forward to make an investment in this sector only after taking due information, and shall select funds that match your investing profile. If you are sceptical about your profile or are apprehensive about your fund choices, then taking the assistance of MySIPonline’s support team is highly recommended. Besides getting free advices on making the best portfolio plan, MySIPonline provides free online portal to submit your funds into various avenues.

So, what are you waiting for? Join the league of successful investors today! Pick your phone and dial MySIPonline, now!